Cochlear Limited, the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration (FDA) approval of three new products to its suite of hearing technology ...

Approval also includes extending the Nucleus 7 Sound Processor to the first U.S. cochlear implant recipients, Custom Sound Pro fitting software to enhance support for hearing professionals LONE TREE, ...

• Kanso combines best-in-class hearing performance with a discreet design that puts hearing loss out of sight Cochlear Limited (ASX: COH), the world leader in implantable hearing solutions, today ...

Cochlear Limited announced yesterday the U.S. Food and Drug Administration clearance of three new products to be added to the company’s suite of hearing technology devices, all of which can connect to ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Cochlear reaffirmed guidance for FY 2025 underlying net profit between $410 million and $430 million, though it expects to achieve the lower end of this range. The revision is driven by weaker ...

While hearing aids are very useful for people with hearing loss, and the technology is constantly evolving and improving, there are still many scenarios where they fall short. The sensitive ...

India, Sep 2: Cochlear Limited released its newest innovation – Kanso – a sound processor combining the most advanced sound processing technology with a discreet design. “Our recipients are at the ...

Upgradeable Firmware: The Cochlear™ Nucleus ® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates.